Experts recently developed 23 consensus practice points/statements regarding the use of nephrectomy in autosomal dominant polycystic kidney disease (ADPKD). Regardless of when it was performed in ...

Please provide your email address to receive an email when new articles are posted on . Nephrectomy can be effectively performed in patients with autosomal dominant PKD for various indications, such ...

Most guidelines still treat indeterminate (Rx) surgical margins after nephrectomy for renal cell carcinoma (RCC) as equivalent to negative (R0) margins, but it is not.

Multimodal Artificial Intelligence Model From Baseline Histopathology Adds Prognostic Information for Distant Recurrence Assessment in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor ...

The value of nephrectomy in metastatic renal-cell cancer has long been debated. Several nonrandomized studies suggest a higher rate of response to systemic therapy and longer survival in patients who ...

Ischemia–reperfusion injury caused by vascular clamping contributes to the decline in glomerular filtration rate following partial nephrectomy. Ischemia is the main modifiable factor that determines ...

1. Which doctor should I consult for undergoing nephrectomy? You should consult a surgeon such as an Urologist. 2. Why should I have a kidney removed? You might have your kidney removed if it is ...

Partial nephrectomy has been the procedure of choice for patients with poor renal function, tumors in solitary kidneys or bilateral renal tumors. The efficacy of partial nephrectomy in regard to ...

a Mean creatinine after 10 years of follow-up. b Median creatinine after median 24 months of follow-up. NR, not reported. Nephron-sparing surgery (NSS) for renal cell carcinoma has the advantage of ...

Increased detection of the small renal mass over the last two decades has led to greater utilization of partial nephrectomy techniques. Appreciation of the negative impact of chronic renal impairment ...

Please provide your email address to receive an email when new articles are posted on . Findings showed no significant differences in surgical outcomes among age groups. Mortality rates were highest ...

Efficacy, safety, and biomarker analysis of neoadjuvant avelumab/axitinib in patients (pts) with localized renal cell carcinoma (RCC) who are at high risk of relapse after nephrectomy (NeoAvAx). This ...